The constitutive expression of BCL6 sustains the lymphoma phenotype and promotes glioblastoma through transcriptional repression of the DNA damage sensor ATR (Ranuncolo et al., 2007) and the p53 pathway (Xu et al., 2017), respectively. The gene discussed is BCL6; the disease is lymphoma.